# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-01-23)

**Core value:** Reliable PHI detection with balanced precision/recall — catch all PHI without over-redacting clinically useful content
**Current focus:** Phase 1: Baseline Measurement

## Current Position

Phase: 1 of 5 (Baseline Measurement)
Plan: Completed Wave 2 (01-03)
Status: In progress - Wave 1 and Wave 2 complete
Last activity: 2026-01-23 — Completed 01-03 (Adversarial Dataset Creation)

Progress: [██████░░░░] 60%

## Performance Metrics

**Velocity:**
- Total plans completed: 5
- Average duration: 6.8 min
- Total execution time: 0.57 hours

**By Phase:**

| Phase | Plans | Total | Avg/Plan |
|-------|-------|-------|----------|
| 01-baseline-measurement | 5/6 | 34 min | 6.8 min |

**Recent Trend:**
- Last 5 plans: 01-01 (3min), 01-02 (1min), 01-03 (12min), 01-04 (3min), 01-03-exec (12min)
- Trend: Execution plans longer (12min) than planning (1-3min)

*Updated after each plan completion*

## Accumulated Context

### Decisions

Decisions are logged in PROJECT.md Key Decisions table.
Recent decisions affecting current work:

- Metrics-based success criteria (Research setting needs defensible evidence; 500 synthetic transcripts enable measurement)
- Balanced precision/recall trade-off (Clinical utility requires readable transcripts; pure aggressive approach over-redacts)
- Case-insensitive deny lists (Consistency prevents edge case bugs; clinical terms appear in various cases)
- F2 as primary metric for PHI detection (False negatives more dangerous than false positives; beta=2 weights recall 2x precision) — From 01-01
- Confusion matrix export as separate CLI flag (Enables threshold calibration without cluttering default output) — From 01-01
- Threshold defaults (recall 95%, precision 70%, F2 90%) (Balance HIPAA compliance with clinical utility) — From 01-04
- CI/CD as v2 implementation (Manual validation sufficient for Phase 1 research focus) — From 01-04
- Separate CI jobs for PHI vs unit tests (Enables parallel execution and independent failure analysis) — From 01-04
- Seed=43 for adversarial dataset (Maintains separation from standard dataset seed=42, enables reproducibility) — From 01-03
- 100 adversarial samples sufficient (Provides full template coverage while keeping evaluation fast) — From 01-03
- 6-category adversarial organization (Groups edge cases by weakness type for clear Phase 4 targeting) — From 01-03

### Pending Todos

None yet.

### Blockers/Concerns

**From Research:**
- Phase 1 blocks all other work — measurement framework must be complete before improvements
- Synthetic data may not represent real transcripts — external validation in Phase 5 is critical
- Weakest entities (PEDIATRIC_AGE 25% adversarial recall, ROOM 19% adversarial recall) require significant pattern work in Phase 4

**From Adversarial Testing (01-03):**
- ROOM patterns critical weakness (19% recall) - misses "Bay 3", "bed 9", single digits, multi-part identifiers
- PEDIATRIC_AGE abbreviations failing (25% recall) - "17yo", "4 yo", "22mo" not covered
- Phone number international formats and extensions need expansion
- MRN bare numbers (no prefix) causing leaks

**Technical Debt:**
- Current thresholds arbitrary (detection 0.35, validation 0.7) — Phase 2 will address
- LOCATION deny list case-sensitive (inconsistent) — Phase 3 will fix
- Room number patterns too narrow (only "Room X" format) — Phase 4 priority #1
- Pediatric age abbreviation patterns missing — Phase 4 priority #2

### Quick Tasks Completed

| # | Description | Date | Commit | Directory |
|---|-------------|------|--------|-----------|
| 001 | Investigate deidentification code | 2026-01-23 | 424cd44 | [001-investigate-deidentification-code](./quick/001-investigate-deidentification-code/) |

## Session Continuity

Last session: 2026-01-23
Stopped at: Completed 01-03 execution (Adversarial Dataset Creation)
Resume file: None
Next: Wave 1 plans (01-01, 01-04) ready for execution

---
*State initialized: 2026-01-23*
*Last updated: 2026-01-23 18:18:43 UTC (after 01-03 execution)*
